EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Screening for endogenous hypercortisolism in patients with osteoporosis and fractures: why, when and how

Roberta Giordano, Mirko Parasiliti Caprino, Paola Loli, Andrea Giustina

Journal of Endocrinological Investigation · 03.10.2024 · 48 (S1) · 23-31

DOI: 10.1007/s40618-024-02450-y ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Endocrinological Investigation, online erschienen am 03.10.2024. Verfasst von Roberta Giordano und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological and Clinical Sciences, University of Turin, Turin, Italy. Hauptthemen laut MEDLINE: Cushing Syndrome, Osteoporotic Fractures, Mass Screening, Osteoporosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Skeletal comorbidities are frequent and clinically relevant findings in Cushing’s syndrome (CS) since an uncoupled suppressed bone formation and enhanced bone resorption leads to a marked skeletal damage with a rapid increase of fracture risk. Reduced Bone Mineral Density (BMD) has been consistently reported and osteopenia or osteoporosis are typical findings in patients with CS. Vertebral Fractures (VFs) are frequently reported and may occur even in patients with an only mild reduction of BMD. Since CS is diagnosed late due to often difficult biochemical and radiological confirmation as well as to signs and symptoms common in other much more frequent diseases an approach suggested for overcoming underdiagnosis is to screen patients with manifestations which may overlap with those of CS such as arterial hypertension, diabetes mellitus and osteoporosis. Our review will focus on the rationale and best practice for screening osteoporotic patients for CS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cushing SyndromeOsteoporotic FracturesMass ScreeningOsteoporosisHumansSpinal FracturesBone Density

Stichwörter der Autor:innen

Bone mineral densityCushing’s syndromeGlucocorticoidsOsteoporosisScreeningVertebral fracturesVertebral morphometry

Autor:innen und Institutionen

  • Department of Biological and Clinical Sciences, University of Turin, Turin, Italy.
  • Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Institute of Endocrine and Metabolic Sciences (IEMS), Università Vita-Salute San Raffaele IRCCS Ospedale San Raffaele, Via Olgettina, 58, Milano, 20132, Italy.
  • Institute of Endocrine and Metabolic Sciences (IEMS), Università Vita-Salute San Raffaele IRCCS Ospedale San Raffaele, Via Olgettina, 58, Milano, 20132, Italy. giustina.andrea@hsr.it.

Zitieren

APA

Giordano, R., Parasiliti Caprino, M., Loli, P., & Giustina, A. (2024). Screening for endogenous hypercortisolism in patients with osteoporosis and fractures: why, when and how. Journal of Endocrinological Investigation, 48(S1), 23-31. https://doi.org/10.1007/s40618-024-02450-y

Vancouver

Giordano R, Parasiliti Caprino M, Loli P, Giustina A. Screening for endogenous hypercortisolism in patients with osteoporosis and fractures: why, when and how. Journal of Endocrinological Investigation. 2024;48(S1):23-31. doi:10.1007/s40618-024-02450-y

BibTeX
@article{Giordano2024,
  author = {Giordano, Roberta and Parasiliti Caprino, Mirko and Loli, Paola and Giustina, Andrea},
  title = {Screening for endogenous hypercortisolism in patients with osteoporosis and fractures: why, when and how},
  journal = {Journal of Endocrinological Investigation},
  year = {2024},
  volume = {48},
  number = {S1},
  pages = {23--31},
  doi = {10.1007/s40618-024-02450-y}
}
Kostenlos starten →